A detailed history of Eisler Capital Management Ltd. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Eisler Capital Management Ltd. holds 78,300 shares of BMY stock, worth $3.67 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
78,300
Previous 131,300 40.37%
Holding current value
$3.67 Million
Previous $6.08 Million 41.9%
% of portfolio
0.02%
Previous 0.04%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 13, 2025

BUY
$43.31 - $48.98 $2.46 Million - $2.78 Million
56,819 Added 99.98%
113,651 $5.13 Million
Q2 2025

Aug 12, 2025

BUY
$44.12 - $59.6 $2 Million - $2.7 Million
45,233 Added 389.97%
56,832 $2.63 Million
Q1 2025

May 14, 2025

SELL
$53.9 - $63.11 $488,549 - $572,029
-9,064 Reduced 43.87%
11,599 $707,000
Q4 2024

Feb 14, 2025

BUY
$51.92 - $59.94 $1.07 Million - $1.24 Million
20,663 New
20,663 $1.17 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $99.5B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Eisler Capital Management Ltd. Portfolio

Follow Eisler Capital Management Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eisler Capital Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Eisler Capital Management Ltd. with notifications on news.